PL1720999T3 - Sposoby wykrywania zanieczyszczeń mikrobiologicznych w roztworach do dializy otrzewnowej - Google Patents

Sposoby wykrywania zanieczyszczeń mikrobiologicznych w roztworach do dializy otrzewnowej

Info

Publication number
PL1720999T3
PL1720999T3 PL05713781T PL05713781T PL1720999T3 PL 1720999 T3 PL1720999 T3 PL 1720999T3 PL 05713781 T PL05713781 T PL 05713781T PL 05713781 T PL05713781 T PL 05713781T PL 1720999 T3 PL1720999 T3 PL 1720999T3
Authority
PL
Poland
Prior art keywords
detection
methods
peritoneal dialysis
dialysis solutions
microbial contaminants
Prior art date
Application number
PL05713781T
Other languages
English (en)
Inventor
Leo Martis
Mehul Patel
Joseph A Giertych
James W Mongoven
Jacqueline A Kunzler
William F Owen Jr
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34887248&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1720999(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Publication of PL1720999T3 publication Critical patent/PL1720999T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4722—Proteoglycans, e.g. aggreccan
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • External Artificial Organs (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL05713781T 2004-02-27 2005-02-18 Sposoby wykrywania zanieczyszczeń mikrobiologicznych w roztworach do dializy otrzewnowej PL1720999T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/789,320 US7118857B2 (en) 2004-02-27 2004-02-27 Methods and compositions for detection of microbial contaminants in peritoneal dialysis solutions
PCT/US2005/005187 WO2005093087A1 (en) 2004-02-27 2005-02-18 Methods and compositions for detection of microbial contaminants in peritoneal dialysis solutions
EP05713781A EP1720999B1 (en) 2004-02-27 2005-02-18 Methods for detection of microbial contaminants in peritoneal dialysis solutions

Publications (1)

Publication Number Publication Date
PL1720999T3 true PL1720999T3 (pl) 2009-07-31

Family

ID=34887248

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05713781T PL1720999T3 (pl) 2004-02-27 2005-02-18 Sposoby wykrywania zanieczyszczeń mikrobiologicznych w roztworach do dializy otrzewnowej

Country Status (17)

Country Link
US (4) US7118857B2 (pl)
EP (1) EP1720999B1 (pl)
JP (2) JP5334412B2 (pl)
KR (1) KR100940173B1 (pl)
CN (2) CN101879181A (pl)
AR (2) AR047900A1 (pl)
AT (1) ATE421997T1 (pl)
AU (1) AU2005226756B2 (pl)
BR (1) BRPI0508219A (pl)
CA (1) CA2555209A1 (pl)
DE (1) DE602005012574D1 (pl)
DK (1) DK1720999T3 (pl)
ES (1) ES2321631T3 (pl)
PL (1) PL1720999T3 (pl)
SG (2) SG145769A1 (pl)
TW (1) TWI344368B (pl)
WO (1) WO2005093087A1 (pl)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8450079B2 (en) 2003-10-31 2013-05-28 Immunetics, Inc. Method for detecting bacteria
US7118857B2 (en) 2004-02-27 2006-10-10 Baxter International Inc. Methods and compositions for detection of microbial contaminants in peritoneal dialysis solutions
US8202248B2 (en) 2004-08-18 2012-06-19 Sequana Medical Ag Dialysis implant and methods of use
US20090239238A1 (en) * 2008-03-20 2009-09-24 Baxter International Inc. Methods for measuring pro-inflammatory substance levels in dialysis solutions and dialysis components
US20090239819A1 (en) * 2008-03-20 2009-09-24 Run Wang Peritoneal dialysis solution test method
US8349813B2 (en) * 2008-03-20 2013-01-08 Baxter International Inc. Destruction of microbial products by enzymatic digestion
US20090269733A1 (en) * 2008-04-23 2009-10-29 Azko, Inc. Devices and Methods for the Rapid Analysis of Pathogens in Biological Fluids
US8882700B2 (en) 2008-05-02 2014-11-11 Baxter International Inc. Smart patient transfer set for peritoneal dialysis
US9348975B2 (en) 2008-05-02 2016-05-24 Baxter International Inc. Optimizing therapy outcomes for peritoneal dialysis
US8057679B2 (en) 2008-07-09 2011-11-15 Baxter International Inc. Dialysis system having trending and alert generation
US8377012B2 (en) 2009-01-30 2013-02-19 Baxter International Inc. Transfer sets for therapy optimization
US8282829B2 (en) 2009-05-20 2012-10-09 Baxter International Inc. System and method for automated data collection of twenty-four hour ultrafiltration and other patient parameters using wired or wireless technology
US9020827B2 (en) 2009-10-16 2015-04-28 Baxter International Inc. Peritoneal dialysis optimized using a patient hand-held scanning device
FR2955861B1 (fr) 2010-02-02 2013-03-22 Roquette Freres Polymeres solubles de glucose branches pour la dialyse peritoneale
US20140083869A1 (en) * 2011-02-09 2014-03-27 University Of Massachusetts Detection Of Endotoxins
GB2503162B (en) 2011-03-23 2018-08-22 Nxstage Medical Inc Peritoneal dialysis systems and devices
US9861733B2 (en) 2012-03-23 2018-01-09 Nxstage Medical Inc. Peritoneal dialysis systems, devices, and methods
EP2609918A1 (en) * 2011-12-27 2013-07-03 Zytoprotec GmbH Peritoneal dialysis fluid comprising a GSK-3 inhibitor
US8585635B2 (en) 2012-02-15 2013-11-19 Sequana Medical Ag Systems and methods for treating chronic liver failure based on peritoneal dialysis
JP6244356B2 (ja) * 2012-05-29 2017-12-06 ロケット フレールＲｏｑｕｅｔｔｅ Ｆｒｅｒｅｓ グルコースポリマーおよびグルコースポリマー加水分解物の製造回路の除染方法
EP2900802A4 (en) 2012-09-25 2016-05-25 Gen Electric DISPOSABLE CONTAINER FOR COLLECTING BIOCONTAMINATED SAMPLES AND DETECTION OF MICROBES IN THESE
US9227005B2 (en) * 2013-03-14 2016-01-05 Brian J LeBerthon Method and device for treating cancer
EP2979091B1 (fr) 2013-03-26 2018-04-25 Roquette Freres Dosage biologique des peptidoglycanes
US9382591B2 (en) * 2013-06-06 2016-07-05 Pall Corporation Compositions for detecting Alicyclobacillus microorganisms
CN103467608B (zh) * 2013-09-27 2015-08-26 华仁药业股份有限公司 艾考糊精及其制备方法
RU2641960C2 (ru) * 2013-12-16 2018-01-23 Дмитрий Анатольевич Складнев Способ обнаружения микробной и вирусной контаминации растворов и биологических жидкостей
MX2016009774A (es) * 2014-02-07 2016-11-14 Roquette Freres Ensayo biologico de peptidoglicanos.
WO2017176695A1 (en) * 2016-04-04 2017-10-12 Medtronic, Inc. Peritoneal dialysate fluid generation system
CA3034358A1 (en) 2016-08-26 2018-03-01 Sequana Medical Ag Systems and methods for managing and analyzing data generated by an implantable device
GB201616718D0 (en) * 2016-09-30 2016-11-16 Microbiosensor Limited Microbial sensing devices
US11559618B2 (en) 2017-05-24 2023-01-24 Sequana Medical Nv Formulations and methods for direct sodium removal in patients having severe renal dysfunction
EP3641850B1 (en) 2017-06-24 2024-10-09 NxStage Medical Inc. Peritoneal dialysis fluid preparation systems
AU2018223035A1 (en) * 2017-10-03 2019-04-18 Medtronic, Inc. Peritoneal dialysate temperature regulation system
US11872337B2 (en) 2018-02-28 2024-01-16 Nxstage Medical, Inc. Fluid preparation and treatment devices methods and systems
WO2020023754A1 (en) * 2018-07-26 2020-01-30 Baxter International Inc. Peritoneal dialysis system with sensors and configured to diagnose peritonitis
CN109400722A (zh) * 2018-11-13 2019-03-01 华仁药业股份有限公司 一种用于去除淀粉水解物中肽聚糖的方法
CN109264812A (zh) * 2018-11-13 2019-01-25 华仁药业股份有限公司 一种用于去除淀粉水解物中内毒素的方法
US11280788B2 (en) * 2019-01-31 2022-03-22 Fresenius Medical Care Holdings, Inc. Rapid diagnosis of peritonitis in peritoneal dialysis patients
AU2023232562A1 (en) 2022-03-08 2024-09-05 Equashield Medical Ltd Fluid transfer station in a robotic pharmaceutical preparation system

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761237A (en) * 1981-07-10 1988-08-02 Baxter Travenol Laboratories, Inc. Peritoneal dialysis solution containing carbohydrate polymers
US4886789A (en) * 1983-01-12 1989-12-12 M. L. Laboratories Plc Peritoneal dialysis and compositions for use therein
US6077836A (en) * 1983-01-12 2000-06-20 Ml Laboratotries, Plc Peritoneal dialysis and compositions for use therein
DE3689863T2 (de) 1985-06-22 1995-01-05 Ml Lab Plc In kontinuierlicher Peritonealdialyse verwendete Polymere.
US6248726B1 (en) * 1985-06-22 2001-06-19 M L Laboratories Plc Method of peritoneal dialysis using glucose polymer solutions
ES2068180T3 (es) * 1986-12-03 1995-04-16 Wako Pure Chem Ind Ltd Reactivos para determinar peptidoglicano y beta-1,3-glucano.
DE4242926C2 (de) 1992-12-18 1994-12-15 Fresenius Ag Dialyselösung für die Peritonealdialyse
TW265263B (pl) * 1993-01-19 1995-12-11 Baxter Int
FR2716199B1 (fr) 1994-02-15 1996-04-26 Roquette Freres Procédé de fabrication d'un hydrolysat d'amidon à faible indice de polymolécularité, nouvel hydrolysat d'amidon ainsi obtenu et son utilisation en dialyse péritonéale.
DE19748290B8 (de) 1997-10-31 2009-09-03 Fresenius Medical Care Deutschland Gmbh Lösung für die Peritonealdialyse
US6770148B1 (en) * 1998-12-04 2004-08-03 Baxter International Inc. Peritoneal dialysis solution containing modified icodextrins
JP2002037705A (ja) * 2000-07-26 2002-02-06 National Agricultural Research Organization 耐酸耐熱性細菌用抗菌剤
US20040121982A1 (en) * 2002-12-20 2004-06-24 Leo Martis Biocompatible dialysis fluids containing icodextrins
US7118857B2 (en) 2004-02-27 2006-10-10 Baxter International Inc. Methods and compositions for detection of microbial contaminants in peritoneal dialysis solutions

Also Published As

Publication number Publication date
ATE421997T1 (de) 2009-02-15
TW200538137A (en) 2005-12-01
JP2007525506A (ja) 2007-09-06
EP1720999B1 (en) 2009-01-28
US20130338102A1 (en) 2013-12-19
JP2011140519A (ja) 2011-07-21
DK1720999T3 (da) 2009-05-04
JP5334412B2 (ja) 2013-11-06
BRPI0508219A (pt) 2007-07-17
WO2005093087A1 (en) 2005-10-06
AR098287A2 (es) 2016-05-26
CN101879181A (zh) 2010-11-10
US8546097B2 (en) 2013-10-01
SG145769A1 (en) 2008-09-29
AU2005226756B2 (en) 2008-08-28
US20050191717A1 (en) 2005-09-01
US8859222B2 (en) 2014-10-14
TWI344368B (en) 2011-07-01
KR20060126571A (ko) 2006-12-07
CA2555209A1 (en) 2005-10-06
DE602005012574D1 (de) 2009-03-19
ES2321631T3 (es) 2009-06-09
US20100056990A1 (en) 2010-03-04
EP1720999A1 (en) 2006-11-15
KR100940173B1 (ko) 2010-02-03
AU2005226756A1 (en) 2005-10-06
US20060263842A1 (en) 2006-11-23
US7118857B2 (en) 2006-10-10
CN1918302A (zh) 2007-02-21
US7618392B2 (en) 2009-11-17
SG158178A1 (en) 2010-01-29
AR047900A1 (es) 2006-03-01

Similar Documents

Publication Publication Date Title
PL1720999T3 (pl) Sposoby wykrywania zanieczyszczeń mikrobiologicznych w roztworach do dializy otrzewnowej
EP1979020A4 (en) PERITONEAL DIALYSIS METHODS AND APPARATUS
IL189221A0 (en) Pyrazine derivatives and uses thereof in renal monitoring
EP1955723A4 (en) BLOOD DIALYSIS AND BLOOD DIALYSIS PROCEDURE
EP1753485B8 (de) Beutelset für die peritonealdialyse und dessen verwendung
IL197220A (en) A method for preparing the concentration of functional groups containing fc in a protein-containing fluid containing functional groups fc
EG27009A (en) System and method for managing water content in a fluid
HK1125873A1 (en) Method and apparatus for home dialysis
GB0501944D0 (en) Compounds for use in chemical detection and/or quantitation
EP2059325A4 (en) OXYGEN CONCENTRATION SYSTEM AND METHOD
EP1846001A4 (en) SYSTEMS AND METHOD FOR THE ADMINISTRATION OF PERITONEAL DIALYSIS SOLUTIONS
IL186032A0 (en) System and method for managing water content in a fluid
IL185441A0 (en) Cellulose solutions in ionic liquids
EP1971378A4 (en) METHOD AND APPARATUS FOR HYPOTHERMIC TREATMENT AND / OR PERITONEAL CAVITY REANIMATION
HK1082441A1 (en) Peritoneal dialysis method
AU304281S (en) Peritoneal dialysis cycler
EP1888210A4 (en) METHODS AND APPARATUS FOR HEMODIALYSIS
HK1097459A1 (en) Peritoneal dialysis solution
EP1890686A4 (en) peritoneal
EP1878430A4 (en) peritoneal
EP1877153A4 (en) METHOD AND SYSTEM FOR STORING AND PURIFYING FLUID
EP1926825A4 (en) METHODS FOR DETECTING AND CHARACTERIZING MICROORGANISMS
GB0609612D0 (en) Detection method and kit
ZA200802296B (en) Improvements in or relating to containers and permeable films
GB0600036D0 (en) System and method for finding integer solutions